Complexes Derived from Heterohybrid Cells and Uses Thereof
    1.
    发明申请
    Complexes Derived from Heterohybrid Cells and Uses Thereof 审中-公开
    来自杂种杂交细胞的复合物及其用途

    公开(公告)号:US20100247562A1

    公开(公告)日:2010-09-30

    申请号:US12438685

    申请日:2007-08-24

    摘要: The present invention relates, generally, to pharmaceutical compositions comprising Heat Shock Proteins (HSPs) and HSP complexes recovered from heterohybrid cells that are generated from the fusion of a first type of cell (Type I) with a second type of cell (Type II). In further embodiments, the present invention relates to preparing HSPs and/or HSP complexes recovered from heterohybrid, and to methods to treat and/or prevent diseases, such as cancer and infectious diseases by administering a pharmaceutical composition comprising a HSP and/or HSP complex recovered from heterohybrid cells that are generated from the fusion of a first type of cell (Type I) with a second type of cell (Type II).

    摘要翻译: 本发明通常涉及包含从第一类型细胞(I型)与第二类型细胞(II型)的融合产生的从异源杂交细胞中回收的热休克蛋白(HSP)和HSP复合物的药物组合物, 。 在进一步的实施方案中,本发明涉及制备从杂合杂交体回收的HSP和/或HSP复合物,以及通过施用包含HSP和/或HSP复合物的药物组合物来治疗和/或预防疾病如癌症和感染性疾病的方法 从由第一类型细胞(I型)与第二类型细胞(II型)的融合产生的杂合杂交细胞中回收。